Nutritional and Metabolic Derangements in Pancreatic Cancer and Pancreatic Resection
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Pancreatic cancer is an aggressive malignancy with a poor prognosis. The disease and its treatment can cause significant nutritional impairments that often adversely impact patient quality of life (QOL). The pancreas has both exocrine and endocrine functions and, in the setting of cancer, both systems may be affected. Pancreatic exocrine insufficiency (PEI) manifests as weight loss and steatorrhea, while endocrine insufficiency may result in diabetes mellitus. Surgical resection, a central component of pancreatic cancer treatment, may induce or exacerbate these dysfunctions. Nutritional and metabolic dysfunctions in patients with pancreatic cancer lack characterization, and few guidelines exist for nutritional support in patients after surgical resection. We reviewed publications from the past two decades (1995–2016) addressing the nutritional and metabolic status of patients with pancreatic cancer, grouping them into status at the time of diagnosis, status at the time of resection, and status of nutritional support throughout the diagnosis and treatment of pancreatic cancer. Here, we summarize the results of these investigations and evaluate the effectiveness of various types of nutritional support in patients after pancreatectomy for pancreatic adenocarcinoma (PDAC). We outline the following conservative perioperative strategies to optimize patient outcomes and guide the care of these patients: (1) patients with albumin < 2.5 mg/dL or weight loss > 10% should postpone surgery and begin aggressive nutrition supplementation; (2) patients with albumin < 3 mg/dL or weight loss between 5% and 10% should have nutrition supplementation prior to surgery; (3) enteral nutrition (EN) should be preferred as a nutritional intervention over total parenteral nutrition (TPN) postoperatively; and, (4) a multidisciplinary approach should be used to allow for early detection of symptoms of endocrine and exocrine pancreatic insufficiency alongside implementation of appropriate treatment to improve the patient’s quality of life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M., & Matrisian, L. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0155 · Cited by 7,094 · cited 1×
“PDAC is expected to be the second leading cause of cancer-related mortality by 2030 [1,2].”
Backgroundβ-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Gibbs, J. (1999) · Archives of Surgery · doi:10.1001/archsurg.134.1.36 · Cited by 1,005 · cited 1×
“1 mg/dL, is a common surrogate marker of malnutrition and is independently associated with greater postoperative complications, such as surgical site infections (SSI) and postoperative morbidity and mortality [18,21,22,27].”
BackgroundHospital Malnutrition: Prevalence, Identification and Impact on Patients and the Healthcare System
Barker, L. A., Gout, B. S., & Crowe, T. C. (2011) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph8020514 · Cited by 985 · cited 1×
“Malnutrition is found in 50%–80% of gastrointestinal cancer patients and is associated with worse outcomes and longer hospital stays [72,73].”
BackgroundGouma, D. J., van Geenen, R. C. I., van Gulik, T. M., de Haan, R. J., de Wit, L. T., Busch, O. R. C., & Obertop, H. (2000) · Annals of Surgery · doi:10.1097/00000658-200012000-00007 · Cited by 836 · cited 1×
“Postoperative morbidity and mortality following PD has significantly improved over the past several decades, however, a complication rate of approximately 40% persists on national level [74].”
BackgroundPrevalence and Clinical Profile of Pancreatic Cancer–Associated Diabetes Mellitus
Pannala, R., Leirness, J. B., Bamlet, W. R., Basu, A., Petersen, G. M., & Chari, S. T. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.039 · Cited by 621 · cited 6×
“DM resolution occurred in 20%–57% of patients after PD [19,32,41], and 13% of patients after DP [33].”
BackgroundInfluentialNutritional predictors of postoperative outcome in pancreatic cancer
Kanda, M., Fujii, T., Kodera, Y., Nagai, S., Takeda, S., & Nakao, A. (2011) · Journal of British Surgery · doi:10.1002/bjs.7305 · Cited by 609 · cited 5×
“1 mg/dL, is a common surrogate marker of malnutrition and is independently associated with greater postoperative complications, such as surgical site infections (SSI) and postoperative morbidity and mortality [18,21,22,27].”
BackgroundInfluentialGiovannucci, E., & Michaud, D. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.050 · Cited by 543 · cited 1×
“NODM, defined as DM diagnosed within 12 months, is associated to a two-fold higher incidence of pancreatic cancer [67].”
BackgroundCachexia Worsens Prognosis in Patients with Resectable Pancreatic Cancer
Bachmann, J., Heiligensetzer, M., Krakowski-Roosen, H., Büchler, M. W., Friess, H., & Martignoni, M. E. (2008) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-008-0505-z · Cited by 428
Enteral Nutrition During Multimodality Therapy in Upper Gastrointestinal Cancer Patients
Daly, J. M., Weintraub, F. N., Shou, J., Rosato, E. F., & Lucia, M. (1995) · Annals of Surgery · doi:10.1097/00000658-199504000-00002 · Cited by 347 · cited 1×
“Previous studies have shown mixed results with an immune-enhancing formula (IEF) [54,55].”
Result
Cited by
Melloul, E., Lassen, K., Roulin, D., Grass, F., Perinel, J., Adham, M., Wellge, E. B., Kunzler, F., Besselink, M. G., Asbun, H., et al. (2020) · World Journal of Surgery · doi:10.1007/s00268-020-05462-w · Cited by 536
Cos, H., Li, D., Williams, G., Chininis, J., Dai, R., Zhang, J., Srivastava, R., Raper, L., Sanford, D., Hawkins, W., et al. (2021) · Journal of Medical Internet Research · doi:10.2196/23595 · Cited by 63
Metadata
- Authors
- Gilliland, T., Villafane-Ferriol, N., Shah, K., Shah, R., Tran Cao, H., Massarweh, N., Silberfein, E., Choi, E., Hsu, C., McElhany, A., Barakat, O., Fisher, W., & Van Buren, G.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2017-03-07
- Volume
- 9
- Issue
- 3
- Pages
- 243
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W2593738187
- Cited by
- 227
- References
- 64
- FWCI
- 13.96
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nutritional and Metabolic Derangements in Pancreatic Cancer and Pancreatic Resection. https://app.cochat.ai/papers/10.3390/nu9030243
- The paper
- Gilliland, T., Villafane-Ferriol, N., Shah, K., Shah, R., Tran Cao, H., Massarweh, N., Silberfein, E., Choi, E., Hsu, C., McElhany, A., Barakat, O., Fisher, W., & Van Buren, G. (2017). Nutritional and Metabolic Derangements in Pancreatic Cancer and Pancreatic Resection. Nutrients. https://doi.org/10.3390/nu9030243
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.